We have studied a four-generation (23 subjects) African-American family with  o thalassemia and high fetal hemoglobin (HbF) levels. The  o thalassemia in this family is due to the splicing site mutation,  IVS2+1G→A, that leads to aberrant mRNA processing and the absence of  globin. Two members of this family are homozygous for  o thalassemia and are non-anemic. All family members who are heterozygous for the  IVS2+1G→A mutation have elevated HbF, with the exception of two individuals who also have severe ␣-globin chain deficiency. We excluded linkage with the hereditary persistence of fetal hemoglobin loci on chromosomes 6 and X. We also excluded the presence of all previously described determinants in the  globin gene cluster associated with elevated HbF production. One thalassemia allele is in the Cameroon-like (HS2)/Benin-like  globin gene cluster haplotype, and the other is in the Senegal-like (HS2)/Benin-like  globin gene cluster haplotype. We speculate that in the homozygotes, those erythroid cells that express low to absent levels of ␥ globin are selectively destroyed. In contrast, in the heterozygotes, the presence of the normal  globin allele would ameliorate the globin chain imbalance and thus allow survival of erythroid cells that express the abnormal transcript, leading to a typical